BRTX
NASDAQ
$0.32
BioRestorative Therapies Inc (BRTX)
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $8 (+2384.47%)
Market Cap
$8.66M
Revenue 5Y CAGR
+38.99%
FCF 5Y CAGR
+38.56%
Price Chart
Valuation
Market Cap$8.66M
P/S24.97
P/B2.88
Profitability
Total Revenue (TTM)$358K
Gross Profit (TTM)$330K
EBITDA-$14M
Operating Margin-14613%
EPS-$1.16
Growth & Risk
EPS 5Y CAGR-42.76%
Revenue 5Y CAGR+38.99%
FCF 5Y CAGR+38.56%
Sharpe Ratio-0.48